Search results
Axsome's New Drug Is Scoring a Win. Is the Stock a Buy?
Motley Fool· 12 months agoAxsome Therapeutics (NASDAQ: AXSM) stood out last year. The biotech began selling its first two...
Axsome (AXSM) Soars on FDA Nod for Depression Drug, Auvelity
Zacks via Yahoo Finance· 2 years agoThe FDA approves Axsome's (AXSM) Auvelity extended-release tablets for the treatment of major...
FDA Approves First Fast-Acting Drug for Depression That Works Within 1 Week
Prevention via Yahoo News· 2 years agoThe FDA approves an oral medication to treat clinical depression: Auvelity from Axsome Therapeutics....
Can Axsome Hold Out Till Depression Drug Becomes a Blockbuster?
Motley Fool· 1 year agoAxsome Therapeutics' (NASDAQ: AXSM) psychiatric drug Auvelity could reach blockbuster status by the...
Breakthrough antidepressants with fewer side effects could help millions of Americans. Here’s what...
Fortune via Yahoo Finance· 6 months agoAs Americans are increasingly reaching for pharmaceutical solutions for depression—about one in...
FDA approves first fast-acting oral drug for clinical depression
The Hill via Yahoo News· 2 years agoStory at a glance A newly approved treatment for clinical depression is being hailed as a potential...
Axsome (AXSM) Rides on New Drug Approval & Sunosi Buyout
Zacks via Yahoo Finance· 1 year agoAxsome (AXSM) receives FDA approval for Auvelity to treat major depressive disorder in August. The...
Does an $11.5 Billion Opportunity Make This Growth Stock a Buy Now?
Motley Fool· 11 months agoAxsome Therapeutics (NASDAQ: AXSM) stock jumped more than 10% on June 14 after the company made its...
Common Medications Used to Treat Major Depressive Disorder
Verywell Health via Yahoo News· 3 months agoMajor depressive disorder (MDD), also referred to as clinical depression or simply depression, is a...
Boxed Warnings May Not Hinder This Depression Drug's Broad Market Penetration, Analyst Says
Benzinga via Yahoo Finance· 2 years agoLast week, Axsome Therapeutics Inc's (NASDAQ: AXSM) major depression candidate received the...